AI assistant
DEXCOM INC — Director's Dealing 2015
May 4, 2015
30198_dirs_2015-05-04_7b794db8-47a5-48fd-9ac4-af762bcaa6b8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2015-04-30
Reporting Person: GREGG TERRANCE H (Director, Executive Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-05-04 | Common Stock | M | 20000.0 | $8.95 | Acquired | 450626 | Direct |
| 2015-05-04 | Common Stock | S | 20000.0 | $68.0638 | Disposed | 430626 | Direct |
| 2015-04-30 | Common Stock | S | 14250.0 | $67.13 | Disposed | 522139 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-05-04 | Non-Qualified Stock Option (right to buy) | $8.95 | M | 20000.0 | Disposed | 2018-01-02 | Common Stock (20000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 11461 | Indirect |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $68.02 to $68.13. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F2: Included in this number are 207,658 unvested restricted stock units, 35,000 of which were granted on March 8, 2015 and will vest on March 8, 2016, 116,798 unvested restricted stock units granted on March 8, 2014, 5,078 of which shall vest each month through March 8, 2017, and 55,860 unvested restricted stock units granted on March 11, 2013, 5,078 of which shall vest each month through March 11, 2016.
F3: The reporting person contributed Dexcom, Inc. Common Stock to an exchange fund, pursuant to an agreement dated March 5, 2015 to contribute shares of DexCom, Inc. Common Stock in exchange for shares of the exchange fund. The Dexcom, Inc. Common Stock was valued at $67.13 per share for the purposes of determining the number of shares of the exchange fund issuable to the reporting person with respect to the April 30, 2015 closing of the exchange fund.
F4: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.